Thrombin generation and mortality during Staphylococcus aureus sepsis

Microbial Pathogenesis
M Bokarewa, A Tarkowski

Abstract

Sepsis-induced abnormalities of coagulation may contribute to mortality during severe bacterial infection. The aim of this study was to examine changes in coagulation parameters and to assess the role of protein C supplementation during murine S. aureus sepsis. Gram-positive sepsis was characterized by a hypercoagulable state with predominant activation of the external coagulation pathway, registered as an early increase of tissue factor activity and concomitant reduction in protein C. The internal coagulation pathway was unaffected. No correlation between the changes of coagulation parameters and the intensity of inflammation, determined as serum IL-6 levels, was found. Supplementation with neither protein C or APC favoured survival in S. aureus sepsis. Reduction in thrombin generation in response to protein C supplementation was associated with significantly increased survival.

References

Mar 1, 1987·The Journal of Clinical Investigation·F B TaylorK E Blick
Nov 1, 1995·Intensive Care Medicine·F FourrierC Chopin
Oct 19, 2000·Arthritis and Rheumatism·M Verdrengh, A Tarkowski

❮ Previous
Next ❯

Citations

Nov 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jacob M RothforkHattie D Gresham
Dec 14, 2002·FEMS Microbiology Letters·Andrej TarkowskiMargareta Verdrengh
Aug 16, 2019·Thrombosis Research·Imre Varjú, Krasimir Kolev

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.